VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q38642741 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010714.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q38642741‏
024 ‎‡a 0000-0003-2953-3284‏ ‎‡2 orcid‏
024 ‎‡a 6602825121‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q38642741‏
100 0 ‎‡a Diego Arango‏ ‎‡9 ast‏ ‎‡9 it‏ ‎‡9 sl‏ ‎‡9 es‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Diego Arango del Corro‏ ‎‡9 fr‏ ‎‡9 pt‏ ‎‡9 ca‏ ‎‡9 de‏ ‎‡9 pt-br‏
400 0 ‎‡a Diego Arango‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Diego Arango del Corro‏ ‎‡c ikertzailea‏ ‎‡9 eu‏
400 0 ‎‡a Diego Arango‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 7q deletion mapping and expression profiling in uterine fibroids.‏
670 ‎‡a Author's A gene expression profile that defines colon cell maturation in vitro.‏
670 ‎‡a Author's A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition‏
670 ‎‡a Author's AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.‏
670 ‎‡a Author's An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor‏
670 ‎‡a Author's An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression‏
670 ‎‡a Author's Apigenin protects endothelial cells from lipopolysaccharide‏
670 ‎‡a Author's Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function‏
670 ‎‡a Author's Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.‏
670 ‎‡a Author's Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.‏
670 ‎‡a Author's Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.‏
670 ‎‡a Author's BB-10010, an analog of macrophage inflammatory protein-1 Alpha, protects murine small intestine against radiation‏
670 ‎‡a Author's BB-10010, an analogue of macrophage inflammatory protein-1 Alpha, reduces proliferation in murine small-intestinal crypts‏
670 ‎‡a Author's Brush border myosin Ia has tumor suppressor activity in the intestine.‏
670 ‎‡a Author's Brush border myosin Ia inactivation in gastric but not endometrial tumors.‏
670 ‎‡a Author's c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.‏
670 ‎‡a Author's c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.‏
670 ‎‡a Author's Cancer stem cells and personalized cancer nanomedicine.‏
670 ‎‡a Author's Candidate driver genes in microsatellite-unstable colorectal cancer‏
670 ‎‡a Author's Clinical response to fluorouracil and p53.‏
670 ‎‡a Author's Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer‏
670 ‎‡a Author's Customizing chemotherapy for colon cancer: the potential of gene expression profiling.‏
670 ‎‡a Author's Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.‏
670 ‎‡a Author's Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine‏
670 ‎‡a Author's Distinct expression profile in fumarate-hydratase-deficient uterine fibroids‏
670 ‎‡a Author's Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status‏
670 ‎‡a Author's Dose-effect relationship of BB-10010/MIP-1 Alpha on proliferation in murine small intestinal epithelium: single and double administration protocols‏
670 ‎‡a Author's Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.‏
670 ‎‡a Author's DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.‏
670 ‎‡a Author's Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells‏
670 ‎‡a Author's EPH receptors in cancer.‏
670 ‎‡a Author's EPHB4 and survival of colorectal cancer patients.‏
670 ‎‡a Author's Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.‏
670 ‎‡a Author's Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs‏
670 ‎‡a Author's Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells‏
670 ‎‡a Author's Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.‏
670 ‎‡a Author's Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer‏
670 ‎‡a Author's Gene expression signatures for colorectal cancer microsatellite status and HNPCC.‏
670 ‎‡a Author's Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families‏
670 ‎‡a Author's HDAC4 promotes growth of colon cancer cells via repression of p21.‏
670 ‎‡a Author's High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.‏
670 ‎‡a Author's Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.‏
670 ‎‡a Author's Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer‏
670 ‎‡a Author's Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.‏
670 ‎‡a Author's Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells‏
670 ‎‡a Author's Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.‏
670 ‎‡a Author's Loss of the EPH receptor B6 contributes to colorectal cancer metastasis‏
670 ‎‡a Author's Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.‏
670 ‎‡a Author's Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer‏
670 ‎‡a Author's Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer‏
670 ‎‡a Author's Microarray analysis in the clinical management of cancer‏
670 ‎‡a Author's Modeling tumor predisposing FH mutations in yeast: effects on fumarase activity, growth phenotype and gene expression profile.‏
670 ‎‡a Author's Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.‏
670 ‎‡a Author's Mutations in the circadian gene CLOCK in colorectal cancer‏
670 ‎‡a Author's Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers‏
670 ‎‡a Author's Myo5b knockout mice as a model of microvillus inclusion disease.‏
670 ‎‡a Author's Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT‏
670 ‎‡a Author's Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer‏
670 ‎‡a Author's Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.‏
670 ‎‡a Author's Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression‏
670 ‎‡a Author's PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab‏
670 ‎‡a Author's PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.‏
670 ‎‡a Author's RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.‏
670 ‎‡a Author's Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis‏
670 ‎‡a Author's Short chain fatty acids and colon cancer‏
670 ‎‡a Author's Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.‏
670 ‎‡a Author's SMAD4 as a Prognostic Marker in Colorectal Cancer‏
670 ‎‡a Author's SMAD4 levels and response to 5-fluorouracil in colorectal cancer‏
670 ‎‡a Author's The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase‏
670 ‎‡a Author's The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.‏
670 ‎‡a Author's The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.‏
670 ‎‡a Author's TR3/Nur77 in colon cancer cell apoptosis.‏
670 ‎‡a Author's Transforming pathways unleashed by a HDAC2 mutation in human cancer.‏
670 ‎‡a Author's Tumor necrosis factor- Alpha related gene response to Epothilone B in ovarian cancer‏
670 ‎‡a Author's Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells‏
670 ‎‡a Author's Unregulated smooth-muscle myosin in human intestinal neoplasia‏
670 ‎‡a Author's Villin expression is frequently lost in poorly differentiated colon cancer.‏
909 ‎‡a (scopus) 6602825121‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000329533284‏ ‎‡9 1‏
919 ‎‡a mechanismsofinactivationofthetumoursuppressorgenerhoaincolorectalcancer‏ ‎‡A Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer‏ ‎‡9 1‏
919 ‎‡a microarrayanalysisintheclinicalmanagementofcancer‏ ‎‡A Microarray analysis in the clinical management of cancer‏ ‎‡9 1‏
919 ‎‡a investigationoftheroleoftyrosinekinasereceptorepha3incolorectalcancer‏ ‎‡A Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a modelingtumorpredisposingfhmutationsinyeasteffectsonfumaraseactivitygrowthphenotypeandgeneexpressionprofile‏ ‎‡A Modeling tumor predisposing FH mutations in yeast: effects on fumarase activity, growth phenotype and gene expression profile.‏ ‎‡9 1‏
919 ‎‡a intracellulardeliveryofantismc2antibodiesagainstcancerstemcells‏ ‎‡A Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells‏ ‎‡9 1‏
919 ‎‡a molecularmechanismsofactionandpredictionofresponsetooxaliplatinincolorectalcancercells‏ ‎‡A Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.‏ ‎‡9 1‏
919 ‎‡a mutationsinthecircadiangeneclockincolorectalcancer‏ ‎‡A Mutations in the circadian gene CLOCK in colorectal cancer‏ ‎‡9 1‏
919 ‎‡a mutationsin2shortnoncodingmononucleotiderepeatsinmostmicrosatelliteunstablecolorectalcancers‏ ‎‡A Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers‏ ‎‡9 1‏
919 ‎‡a humansmc2proteinacoresubunitofhumancondensincomplexisanoveltranscriptionaltargetofthewntsignalingpathwayandanewtherapeutictarget‏ ‎‡A Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.‏ ‎‡9 1‏
919 ‎‡a histonedeacetylase3hdac3andotherclass1hdacsregulatecoloncellmaturationandp21expressionandarederegulatedinhumancoloncancer‏ ‎‡A Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer‏ ‎‡9 1‏
919 ‎‡a myo5bknockoutmiceasamodelofmicrovillusinclusiondisease‏ ‎‡A Myo5b knockout mice as a model of microvillus inclusion disease.‏ ‎‡9 1‏
919 ‎‡a highlyexpressedgenesinrapidlyproliferatingtumorcellsasnewtargetsforcolorectalcancertreatment‏ ‎‡A Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.‏ ‎‡9 1‏
919 ‎‡a highephb2mutationrateingastricbutnotendometrialtumorswithmicrosatelliteinstability‏ ‎‡A High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.‏ ‎‡9 1‏
919 ‎‡a na+monocarboxylatetransportsmctproteinexpressioncorrelateswithsurvivalincoloncancermolecularcharacterizationofsmct‏ ‎‡A Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT‏ ‎‡9 1‏
919 ‎‡a nanotechnologyisanimportantstrategyforcombinationalinnovativechemoimmunotherapiesagainstcolorectalcancer‏ ‎‡A Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer‏ ‎‡9 1‏
919 ‎‡a noveldetectionanddifferentialutilizationofa100myctranscriptionalblockincoloncancerchemoprevention‏ ‎‡A Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.‏ ‎‡9 1‏
919 ‎‡a oncogenickirasinhibitstheexpressionofinterferonresponsivegenesthroughinhibitionofstat1andstat2expression‏ ‎‡A Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression‏ ‎‡9 1‏
919 ‎‡a pik3camutationptenexpressionstatuspredictsresponseofcoloncancercellstotheepidermalgrowthfactorreceptorinhibitorcetuximab‏ ‎‡A PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab‏ ‎‡9 1‏
919 ‎‡a hdac4promotesgrowthofcoloncancercellsviarepressionofp21‏ ‎‡A HDAC4 promotes growth of colon cancer cells via repression of p21.‏ ‎‡9 1‏
919 ‎‡a germlinehypermethylationoftheapcpromoterisnotafrequentcauseoffamilialadenomatouspolyposisinapcmutyhmutationnegativefamilies‏ ‎‡A Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families‏ ‎‡9 1‏
919 ‎‡a ptprdishomozygouslydeletedandepigeneticallydownregulatedinhumanhepatocellularcarcinomas‏ ‎‡A PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.‏ ‎‡9 1‏
919 ‎‡a geneexpressionsignaturesforcolorectalcancermicrosatellitestatusandhnpcc‏ ‎‡A Gene expression signatures for colorectal cancer microsatellite status and HNPCC.‏ ‎‡9 1‏
919 ‎‡a geneexpressionprofilingpredictsrecurrenceindukes100colorectalcancer‏ ‎‡A Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer‏ ‎‡9 1‏
919 ‎‡a geneexpressionprofilingbasedpredictionofresponseofcoloncarcinomacellsto5fluorouracilandcamptothecin‏ ‎‡A Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.‏ ‎‡9 1‏
919 ‎‡a fluorescentcscmodelsevidencethattargetednanomedicinesimprovetreatmentsensitivityofbreastandcoloncancerstemcells‏ ‎‡A Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells‏ ‎‡9 1‏
919 ‎‡a extracellularvesiclessecretedbytriplenegativebreastcancerstemcellstriggerpremetastaticnicheremodelingandmetastaticgrowthinthelungs‏ ‎‡A Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs‏ ‎‡9 1‏
919 ‎‡a expressionofseleniumbindingprotein1characterizesintestinalcellmaturationandpredictssurvivalforpatientswithcolorectalcancer‏ ‎‡A Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a rhoainactivationenhanceswntsignallingandpromotescolorectalcancer‏ ‎‡A RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a serratedcarcinomasformasubclassofcolorectalcancerwithdistinctmolecularbasis‏ ‎‡A Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis‏ ‎‡9 1‏
919 ‎‡a shortchainfattyacidsandcoloncancer‏ ‎‡A Short chain fatty acids and colon cancer‏ ‎‡9 1‏
919 ‎‡a silencingofadaptorproteinsh3bp2reduceskitpdgfrareceptorsexpressionandimpairsgastrointestinalstromaltumorsgrowth‏ ‎‡A Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.‏ ‎‡9 1‏
919 ‎‡a smad4asaprognosticmarkerincolorectalcancer‏ ‎‡A SMAD4 as a Prognostic Marker in Colorectal Cancer‏ ‎‡9 1‏
919 ‎‡a ephb4andsurvivalofcolorectalcancerpatients‏ ‎‡A EPHB4 and survival of colorectal cancer patients.‏ ‎‡9 1‏
919 ‎‡a ephreceptorsincancer‏ ‎‡A EPH receptors in cancer.‏ ‎‡9 1‏
919 ‎‡a dynamismsensitivityandconsequencesofmesenchymalandstemlikephenotypeofcancercells‏ ‎‡A Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells‏ ‎‡9 1‏
919 ‎‡a dusp5ismethylatedincimphighcolorectalcancerbutisnotamajorregulatorofintestinalcellproliferationandtumorigenesis‏ ‎‡A DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.‏ ‎‡9 1‏
919 ‎‡a dualtargetingofbromodomainandextraterminaldomainproteinsandwntormapksignalinginhibits100mycexpressionandproliferationofcolorectalcancercells‏ ‎‡A Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.‏ ‎‡9 1‏
919 ‎‡a doseeffectrelationshipofbb10010mip1 Alpha onproliferationinmurinesmallintestinalepitheliumsingleanddoubleadministrationprotocols‏ ‎‡A Dose-effect relationship of BB-10010/MIP-1 Alpha on proliferation in murine small intestinal epithelium: single and double administration protocols‏ ‎‡9 1‏
919 ‎‡a distinctpatternsofkrasmutationsincolorectalcarcinomasaccordingtogermlinemismatchrepairdefectsandhmlh1methylationstatus‏ ‎‡A Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status‏ ‎‡9 1‏
919 ‎‡a distinctexpressionprofileinfumaratehydratasedeficientuterinefibroids‏ ‎‡A Distinct expression profile in fumarate-hydratase-deficient uterine fibroids‏ ‎‡9 1‏
919 ‎‡a smad4levelsandresponseto5fluorouracilincolorectalcancer‏ ‎‡A SMAD4 levels and response to 5-fluorouracil in colorectal cancer‏ ‎‡9 1‏
919 ‎‡a intestinalepithelialcelldifferentiationmarkerintestinalalkalinephosphatase‏ ‎‡A The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase‏ ‎‡9 1‏
919 ‎‡a intestinalepithelialcelldifferentiationmarkerintestinalalkalinephosphatasealpiisselectivelyinducedbyhistonedeacetylaseinhibitorshdaciincoloncancercellsinakruppellikefactor5klf5dependentmanner‏ ‎‡A The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.‏ ‎‡9 1‏
919 ‎‡a receptortyrosinekinaseephb4hastumorsuppressoractivitiesinintestinaltumorigenesis‏ ‎‡A The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.‏ ‎‡9 1‏
919 ‎‡a tr3nur77incoloncancercellapoptosis‏ ‎‡A TR3/Nur77 in colon cancer cell apoptosis.‏ ‎‡9 1‏
919 ‎‡a transformingpathwaysunleashedbyahdac2mutationinhumancancer‏ ‎‡A Transforming pathways unleashed by a HDAC2 mutation in human cancer.‏ ‎‡9 1‏
919 ‎‡a tumornecrosisfactor Alpha relatedgeneresponsetoepothilonebinovariancancer‏ ‎‡A Tumor necrosis factor- Alpha related gene response to Epothilone B in ovarian cancer‏ ‎‡9 1‏
919 ‎‡a tumourselectionadvantageofnondominantnegativep53mutationsinhomozygoticmdm2snp309colorectalcancercells‏ ‎‡A Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells‏ ‎‡9 1‏
919 ‎‡a unregulatedsmoothmusclemyosininhumanintestinalneoplasia‏ ‎‡A Unregulated smooth-muscle myosin in human intestinal neoplasia‏ ‎‡9 1‏
919 ‎‡a villinexpressionisfrequentlylostinpoorlydifferentiatedcoloncancer‏ ‎‡A Villin expression is frequently lost in poorly differentiated colon cancer.‏ ‎‡9 1‏
919 ‎‡a metastasisassociatedgeneexpressionchangespredictpooroutcomesinpatientswithdukesstageband100colorectalcancer‏ ‎‡A Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer‏ ‎‡9 1‏
919 ‎‡a diagnosticultrasoundinduceschangewithinnumbersofcryptalmitoticandapoptoticcellsinsmallintestine‏ ‎‡A Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine‏ ‎‡9 1‏
919 ‎‡a decreasein100mycactivityenhancescancercellsensitivitytovinblastine‏ ‎‡A Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.‏ ‎‡9 1‏
919 ‎‡a customizingchemotherapyforcoloncancerthepotentialofgeneexpressionprofiling‏ ‎‡A Customizing chemotherapy for colon cancer: the potential of gene expression profiling.‏ ‎‡9 1‏
919 ‎‡a colorectalcancercelllinesarerepresentativemodelsofthemainmolecularsubtypesofprimarycancer‏ ‎‡A Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer‏ ‎‡9 1‏
919 ‎‡a clinicalresponsetofluorouracilandp53‏ ‎‡A Clinical response to fluorouracil and p53.‏ ‎‡9 1‏
919 ‎‡a candidatedrivergenesinmicrosatelliteunstablecolorectalcancer‏ ‎‡A Candidate driver genes in microsatellite-unstable colorectal cancer‏ ‎‡9 1‏
919 ‎‡a cancerstemcellsandpersonalizedcancernanomedicine‏ ‎‡A Cancer stem cells and personalized cancer nanomedicine.‏ ‎‡9 1‏
919 ‎‡a 100mycp53interactiondeterminessensitivityofhumancoloncarcinomacellsto5fluorouracilinvitroandinvivo‏ ‎‡A c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.‏ ‎‡9 1‏
919 ‎‡a 100mycoverexpressionsensitisescoloncancercellstocamptothecininducedapoptosis‏ ‎‡A c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.‏ ‎‡9 1‏
919 ‎‡a brushbordermyosiniainactivationingastricbutnotendometrialtumors‏ ‎‡A Brush border myosin Ia inactivation in gastric but not endometrial tumors.‏ ‎‡9 1‏
919 ‎‡a brushbordermyosiniahastumorsuppressoractivityintheintestine‏ ‎‡A Brush border myosin Ia has tumor suppressor activity in the intestine.‏ ‎‡9 1‏
919 ‎‡a bb10010ananalogueofmacrophageinflammatoryprotein1 Alpha reducesproliferationinmurinesmallintestinalcrypts‏ ‎‡A BB-10010, an analogue of macrophage inflammatory protein-1 Alpha, reduces proliferation in murine small-intestinal crypts‏ ‎‡9 1‏
919 ‎‡a bb10010ananalogofmacrophageinflammatoryprotein1 Alpha protectsmurinesmallintestineagainstradiation‏ ‎‡A BB-10010, an analog of macrophage inflammatory protein-1 Alpha, protects murine small intestine against radiation‏ ‎‡9 1‏
919 ‎‡a aprataxintumorlevelspredictresponseofcolorectalcancerpatientstoirinotecanbasedtreatment‏ ‎‡A Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.‏ ‎‡9 1‏
919 ‎‡a applicationofgeneexpressionprofilingtocoloncellmaturationtransformationandchemoprevention‏ ‎‡A Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.‏ ‎‡9 1‏
919 ‎‡a apoptoticsensitivityofcoloncancercellstohistonedeacetylaseinhibitorsismediatedbyansp1sp3activatedtranscriptionalprograminvolvingimmediateearlygeneinduction‏ ‎‡A Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.‏ ‎‡9 1‏
919 ‎‡a apigeninprotectsendothelialcellsfromlipopolysaccharidelpsinducedinflammationbydecreasingcaspase3activationandmodulatingmitochondrialfunction‏ ‎‡A Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function‏ ‎‡9 1‏
919 ‎‡a apigeninprotectsendothelialcellsfromlipopolysaccharide‏ ‎‡A Apigenin protects endothelial cells from lipopolysaccharide‏ ‎‡9 1‏
919 ‎‡a a13repeatwithinthe3untranslatedregionofepidermalgrowthfactorreceptoregfrisfrequentlymutatedinmicrosatelliteinstabilitycoloncancersandisassociatedwithincreasedegfrexpression‏ ‎‡A An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression‏ ‎‡9 1‏
919 ‎‡a a13repeatwithinthe3untranslatedregionofepidermalgrowthfactorreceptor‏ ‎‡A An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor‏ ‎‡9 1‏
919 ‎‡a akt2sirnadeliverywithamphiphilicbasedpolymericmicellesshowefficacyagainstcancerstemcells‏ ‎‡A AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.‏ ‎‡9 1‏
919 ‎‡a truncatingmutationofhdac2inhumancancersconfersresistancetohistonedeacetylaseinhibition‏ ‎‡A A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition‏ ‎‡9 1‏
919 ‎‡a geneexpressionprofilethatdefinescoloncellmaturationinvitro‏ ‎‡A A gene expression profile that defines colon cell maturation in vitro.‏ ‎‡9 1‏
919 ‎‡a 7qdeletionmappingandexpressionprofilinginuterinefibroids‏ ‎‡A 7q deletion mapping and expression profiling in uterine fibroids.‏ ‎‡9 1‏
919 ‎‡a mechanismsofinactivationofthereceptortyrosinekinaseephb2incolorectaltumors‏ ‎‡A Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.‏ ‎‡9 1‏
919 ‎‡a lossoftheephreceptorb6contributestocolorectalcancermetastasis‏ ‎‡A Loss of the EPH receptor B6 contributes to colorectal cancer metastasis‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BNCHL|10000000000000000825552‏
996 ‎‡2 BNCHL|10000000000000000857927‏
996 ‎‡2 ISNI|0000000079307179‏
996 ‎‡2 SUDOC|188107452‏
996 ‎‡2 RERO|A000111256‏
996 ‎‡2 LC|no2010097697‏
996 ‎‡2 ISNI|0000000080030824‏
996 ‎‡2 JPG|500330173‏
996 ‎‡2 DNB|136716504‏
996 ‎‡2 ISNI|0000000030582479‏
996 ‎‡2 LC|no2008060481‏
996 ‎‡2 ISNI|0000000047272629‏
996 ‎‡2 ISNI|0000000080598831‏
996 ‎‡2 ISNI|000000005017320X‏
996 ‎‡2 LC|n 88268797‏
996 ‎‡2 LC|no2010087985‏
996 ‎‡2 BNCHL|10000000000000000123758‏
996 ‎‡2 SUDOC|228253004‏
996 ‎‡2 LC|nr2001036266‏
996 ‎‡2 LC|nr2001006431‏
996 ‎‡2 ISNI|0000000050248881‏
996 ‎‡2 DNB|1165107422‏
996 ‎‡2 DNB|1157702309‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏